Follow Japan University News

Press releases View all 22 hits

Efficacy of Esophageal Cancer Postoperative Adjuvant Treatment, Peptide Vaccine Treatment, Elucidated 5-year Survival Rate Approx. Doubled for Esophageal Cancer Patients - Kindai University

Efficacy of Esophageal Cancer Postoperative Adjuvant Treatment, Peptide Vaccine Treatment, Elucidated 5-year Survival Rate Approx. Doubled for Esophageal Cancer Patients - Kindai University

Press releases   •   Sep 01, 2020 00:50 UTC

Kindai University’s Faculty of Medicine has, in a world first, shown the efficacy of cancer-specific vaccine therapy as a postoperative adjuvant therapy in a phase 2 clinical trial. Administration of cancer-specific vaccine therapy roughly doubled the 5-year survival rate of advanced esophageal cancer patients. Vaccine therapy amplifying CTL2 is expected to help validate peptide vaccine therapy.

Discovery of Novel Nuclear Structure Inside Fertilized Eggs - Research Results Bring Us Closer to Solving the Riddle of the Development of Animals -- Kindai University

Discovery of Novel Nuclear Structure Inside Fertilized Eggs - Research Results Bring Us Closer to Solving the Riddle of the Development of Animals -- Kindai University

Press releases   •   Jul 07, 2020 05:11 UTC

This research is expected to contribute to the development of reproductive medicine, including human infertility treatment, and animal breeding technology through practical application of the special characteristics of fertilized eggs that were discovered.

Slack for higher education: Kindai to Become First Japanese University to Invigorate University-wide Communications and Smoothen the Delivery of Online Classes - Kindai University

Slack for higher education: Kindai to Become First Japanese University to Invigorate University-wide Communications and Smoothen the Delivery of Online Classes - Kindai University

Press releases   •   Jun 30, 2020 01:11 UTC

- Introduction of Slack aims to build a new communication platform for staff and students institution wide - Utilization of Slack enhances the effectiveness of distance learning solutions - Expansion of student support through user-friendly Slack

Efficacy of Opdivo (Nivolumab) in Cancer of Unknown Primary Cases Confirmed - Kindai University

Efficacy of Opdivo (Nivolumab) in Cancer of Unknown Primary Cases Confirmed - Kindai University

Press releases   •   Jun 11, 2020 08:53 UTC

- Efficacy of molecular target drug Nivolumab verified in investigator-initiated clinical trial for use with CUP by hospital team from Kindai University’s Faculty of Medicine - Reductions by more than half in tumor size in over 20% of CUP patients observed - Nivolumab expected to become standard treatment for CUP cases with no standard treatment

Contacts 1 hit